➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Dow
Harvard Business School
Medtronic
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Institut Biochimique Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INSTITUT BIOCHIMIQUE, and what generic alternatives to INSTITUT BIOCHIMIQUE drugs are available?

INSTITUT BIOCHIMIQUE has two approved drugs.

There are three US patents protecting INSTITUT BIOCHIMIQUE drugs.

There are twenty-one patent family members on INSTITUT BIOCHIMIQUE drugs in eleven countries and one supplementary protection certificate in one country.

Summary for Institut Biochimique
International Patents:21
US Patents:3
Tradenames:2
Ingredients:1
NDAs:2

Drugs and US Patents for Institut Biochimique

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-005 Oct 13, 2006 RX Yes No 7,723,390   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-006 Oct 13, 2006 RX Yes No 7,723,390   Start Trial Y   Start Trial
Institut Biochimique TIROSINT-SOL levothyroxine sodium SOLUTION;ORAL 206977-012 Dec 15, 2016 RX Yes Yes 10,537,538   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-010 Oct 2, 2009 RX Yes No 7,691,411   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Institut Biochimique Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1291021 132012902104794 Italy   Start Trial PRODUCT NAME: LEVOTIROXINA SODICA(ALIASINT); AUTHORISATION NUMBER(S) AND DATE(S): RVG 106848; 106850-106860, 20110407;DA 041528011/M A 041528365/M, 20120808
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Moodys
Express Scripts
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.